| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007373039 |
Sensitive |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034862451 |
Sensitive |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.032575577 |
Sensitive |
